. Author manuscript; available in PMC: 2020 Dec 1.

Published in final edited form as: Br J Haematol. 2019 Jul 12;187(5):588–594. doi: 10.1111/bjh.16096

Table II.

Haematological and organ response among the 10-year survivors

	1^st line therapy N (%)	Best response all lines of therapies N (%)
Haematological response (n=168)
Complete response	104 (62%)	113 (67%)
Very good partial response	43 (25%)	51 (30%)
Partial response	13 (8%)	3 (2%)
No response	8 (5%)	1 (1%)

Organ response (n=165)
Any organ response	125 (76%)	142 (86%)
No organ response	40 (24%)	23 (14%)

Cardiac (n=63)
Response	48 (76%)	51 (81%)
No response	15 (24%)	12 (19%)
Not evaluable (n=22)
Renal (n=117)
Response	92 (79%)	106 (91%)
No response	25 (21%)	11 (9%)
Not evaluable (n=22)
Hepatic (n=33)
Response	29 (88%)	31(94%)
No response	4 (12%)	2 (6%)
Not evaluable (n=1)